Abstract
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. The mainstays of management include early recognition, source control, antibiotic treatment and effective resuscitation. In 2001, early goal-directed therapy (EGDT), a protocol for sepsis resuscitation, demonstrated decreased mortality among emergency department patients randomized to 6 h of EGDT versus usual care. EGDT utilized intravenous fluids, vasopressors, inotropes, and blood transfusions to achieve specific central hemodynamic goals. While this practice was adopted in international guidelines, concerns remain about the validity of this approach. Subsequent multisite randomized controlled trials published in 2014 and 2015 have demonstrated no mortality benefit with the use of EGDT versus usual care. The Surviving Sepsis Campaign (SSC) currently provides best practice guidelines for resuscitation of patients with sepsis and septic shock. Crystalloid is the initial fluid of choice for sepsis; albumin may be safely used as an adjunct for large volume resuscitation in the absence of traumatic injury. SSC endorses quantitative resuscitation within the first 6 h of care to achieve specific central hemodynamic goals and normalization of lactate. Sepsis resuscitation remains an active area for research investigation, and evidence-based guidelines will continue to reflect advances in knowledge.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 6S:
-
Scandinavian starch for severe sepsis/septic shock
- ALBIOS:
-
Albumin Italian outcome sepsis study
- ARISE:
-
Australasian resuscitation in sepsis evaluation
- CHEST:
-
Crystalloid versus hydroxyethyl starch trial
- CRISTAL:
-
Colloids versus crystalloids for the resuscitation of the critically ill
- cu mm:
-
Cubic millimeter
- CVP:
-
Central venous pressure
- EGDT:
-
Early goal-directed therapy
- HES:
-
Hydroxyethyl starch
- ICU:
-
Intensive care unit
- IL:
-
Interleukin
- LPS:
-
Lipopolysaccharide
- MAP:
-
Mean arterial pressure
- mm Hg:
-
Millimeters mercury
- PaCO2 :
-
Partial arterial pressure of carbon dioxide
- PaO2/FIO2 :
-
Ratio of arterial oxygen partial pressure to fractional inspired oxygen
- PAMPs:
-
Pathogen-associated molecular patterns
- ProCESS:
-
Protocolized care for early septic shock
- ProMISe:
-
Protocolized management in sepsis
- QSOFA:
-
Quick Sequential [Sepsis-Related] Organ Failure Assessment Score
- SAFE:
-
Saline versus albumin fluid evaluation
- SBP:
-
Systolic blood pressure
- ScvO2 :
-
Central venous oxygen saturation
- SIRS:
-
Systemic inflammatory response syndrome
- SOFA:
-
Sequential [Sepsis-Related] Organ Failure Assessment Score
- SSC:
-
Surviving sepsis campaign
- SvO2 :
-
Mixed venous oxygen saturation
- TLR:
-
Toll-like receptor
- US:
-
United States
- VISEP:
-
Efficacy of volume substitution and insulin therapy in severe sepsis
References
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315(8):801-810.
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315(8):775-787.
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315(8):762-774.
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA. 1995;273:117–23.
Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin. 2009;25:83–101.
Opal SM. The evolution of the understanding of sepsis, infection, and the host response: a brief history. Crit Care Clin. 2009;25:637–63.
Cerra FB. The systemic septic response: multiple systems organ failure. Crit Care Clin. 1985;1:591–607.
Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s: systemic inflammatory response and organ dysfunction. JAMA. 1994;271:26–233.
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013;41(2):580–637.
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.
Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–73.
Yealy DM, Kellum JA, Huang DT, ProCESS Investigators, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.
ARISE Investigators, ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371:1496–506.
Mouncey PR, Osborn TM, Power GS, ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301–11.
Bone RC, Balk RA, Cerra FB, The ACCP-SCCM Consensus Conference Committee, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–55.
Levy MM, Fink MP, Marshall JC, et al. International sepsis definitions conference. 2001 SSCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med. 2003;31:1250–6.
Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;381:774–5.
Sprung CL, Sakr Y, Vincent JL, et al. An evaluation of systemic inflammatory response syndrome signs in the sepsis occurrence in acutely ill patients (SOAP) study. Intensive Care Med. 2006;32(3):411–7.
Vincent JL. Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med. 2007;25(2):372–4.
Kaukonen K, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372:1629–38.
Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167–74.
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–51.
Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.
Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30:580–8.
Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311:1308–16.
Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010;376:1339–46.
Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ. Hospitalization type predicts risk of subsequent severe sepsis. Am J Respir Crit Care Med. 2015 (in press). Available at http://www.atsjournals.org/doi/abs/10.1164/rccm.201503-0483OC#.Vaf4T5NViko. Accessed 16 July 2015.
Mayr FB, Yende S, Linde-Zwirble WT, et al. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010;303:2495–503.
Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.
van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008;8:32–43.
Cawcutt KA, Peters SG. Severe sepsis and septic shock: clinical overview and update on management. Mayo Clin Proc. 2014;89(11):1572–8.
Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581–90.
Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243–51.
Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2012;6:CD000567.
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE study investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–56.
Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2011;39:386–91.
Annane D, Siami S, Jaber S, CRISTAL Investigators, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310(17):1809–17.
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, ALBIOS Study Investigators, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412–21.
Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561.
Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6 % hydroxyethyl starch 130/0.4 vs. 0.9 % NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care. 2012;16:R94.
Myburgh JA, Finfer S, Bellomo R, CHEST Investigators, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11.
Perner A, Haase N, Guttormsen AB, 6S Trial Group, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124–34.
Brunkhorst FM, Engel C, Bloos F, German Competence Network Sepsis (SepNet), et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.
Monnet X, Teboul J. Assessment of volume responsiveness during mechanical ventilation: recent advances. Crit Care. 2013;17(2):217.
Prekker ME, Scott NL, Hart D, Sprenkle MD, Leatherman JW. Point-of-care ultrasound to estimate central venous pressure: a comparison of three techniques. Crit Care Med. 2013;41(3):833–41.
Angus DC, Barnato AE, Bell D et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med. 2015. Available at http://link.springer.com.ezp.welch.jhmi.edu/article/10.1007%2Fs00134-015-3822-1. Accessed 19 July 2015.
Jones AE, Shapiro NI, Trzeciak S, Emergency Medicine Shock Research Network (EMShockNet) Investigators, et al. Lactate clearance vs central venous oxygen saturation goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739–46.
Jansen TC, van Bommel J, Schoonderbeek FJ, LACTATE Study Group, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kodadek, L.M., Lipsett, P.A. (2017). Resuscitation of the Patient in Septic Shock. In: Diaz, J., Efron, D. (eds) Complications in Acute Care Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-42376-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-42376-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42374-6
Online ISBN: 978-3-319-42376-0
eBook Packages: MedicineMedicine (R0)